Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

PMV veers toward $100m IPO

PMV Pharmaceuticals – built on foundational work at Princeton – will use some of the proceeds to complete phase 1 trials of its lead asset.


Sep 10, 2020

Daily deal net: September 9, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 9, 2020

Järrsten to decamp from Karolinska Development

Fredrik Järrsten has quit his role as CFO and deputy CEO of Karolinska Development after helping steer the firm's financial turnaround.

Sep 9, 2020

Daily deal net: September 8, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 8, 2020

Solar Foods absorbs series A funding

VTT spinout Solar Foods, developer of a method of creating protein from air, has increased a series A round led by strategic partner Fazer Group to $20.7m.

Sep 8, 2020

Rosten joins Frontier IP’s roster

Frontier IP has secured the services of software development veteran Mark Rosten to supervise IT deal flow and product deployment at its portfolio companies.

Sep 8, 2020

Alkahest aligns with Grifols for $146m acquisition

Grifols has acquired its existing portfolio company Alkahest, five years after buying a 45% stake in the Stanford University spinout.

Sep 8, 2020

Daily deal net: September 7, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 7, 2020

CoWin confirms $35.9m

Backed by Research Institute of Tsinghua University in Shenzhen, CoWin Biosciences supplies biological reagents for diagnostics and research applications.

Sep 7, 2020

QuantaMatrix to match up $71.8m IPO

QuantaMatrix is targeting $17.80 to $22.30 per share under a regulation permitting a listing on the basis of growth and technology potential.

Sep 7, 2020

Taysha tilts toward public markets

UT Southwestern-linked CNS disease drug developer Taysha has filed to raise up to $100m in an IPO, just weeks after its $96m series B.

Sep 4, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here